Dynamic Pharmaceuticals Powershares (PJP) 75.81 $P
Post# of 64200
Posted On: 02/28/2015 8:08:59 PM
Dynamic Pharmaceuticals Powershares (PJP) 75.81 $PJP
Pharma ETFs In Focus On Valeant-Salix Deal
Zacks Funds - Seeking Alpha - Wed Feb 25, 6:44AM CST
After a blockbuster 2014, the healthcare space continues its mergers and acquisitions this year as well. The latest catalyst in the space is the Canadian drug maker Valeant Pharmaceuticals International (NYSE: VRX ), which is set to acquire leading...
PPH: 69.20 (-0.28), VRX: 197.48 (-3.77), PJP: 75.81 (-0.55), SLXP: 157.20 (+0.25), XPH: 123.68 (-1.05)
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Feb 24, 8:00AM CST
The M&A deal has put the pharma ETFs in focus over the coming days.
PPH: 69.20 (-0.28), VRX: 197.48 (-3.77), PJP: 75.81 (-0.55), SLXP: 157.20 (+0.25), XPH: 123.68 (-1.05)
Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 54.82 (-0.72), HQL: 28.10 (-0.22), FBT: 115.23 (-0.93), PJP: 75.81 (-0.55), XBI: 214.63 (-3.26), XPH: 123.68 (-1.05), IBB: 337.47 (-3.33), HQH: 35.19 (-0.24)
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 05, 10:00AM CST
How pharma ETFs are looking after the string of earnings beat and disappointing guidance?
IHE: 168.40 (-1.32), JNJ: 102.51 (-0.29), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), MRK: 58.54 (-0.42), PFE: 34.32 (-0.27), LLY: 70.17 (+0.14), BMY: 60.92 (-0.54)
Can Pharma ETFs Continue Their Uptrend In 2015?
Zacks Funds - Seeking Alpha - Fri Jan 09, 4:37PM CST
The pharmaceutical sector, which had been witnessing several tax inversion deals over the last few months, is not likely to go down this route given the Sep 2014 notice issued by the U.S. Department of the Treasury. New rules imposed by the Treasury...
IHE: 168.40 (-1.32), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), XPH: 123.68 (-1.05)
Can Pharma ETFs Continue their Uptrend in 2015? - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jan 09, 11:00AM CST
Several factors suggest that Pharma ETFs may continue their strong performance this year as well.
IHE: 168.40 (-1.32), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), XPH: 123.68 (-1.05)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 30.13 (-0.29), RXL: 138.47 (-1.10), XBI: 214.63 (-3.26), IHE: 168.40 (-1.32), IHF: 127.24 (+0.23), PPH: 69.20 (-0.28), XHE: 93.16 (-0.49), BBC: 31.07 (-0.57), PTH: 58.61 (-0.63), BBH: 127.98 (-1.22), FHLC: 35.00 (-0.18), IHI: 119.02 (-0.51), CURE: 144.50 (-2.04), FXH: 64.53 (-0.35), VHT: 133.62 (-0.69), RYH: 151.78 (-0.58), PBE: 54.82 (-0.72), IYH: 153.01 (-0.71), FBT: 115.23 (-0.93), XHS: 120.36 (+0.82), XPH: 123.68 (-1.05), XLV: 72.24 (-0.35), SBIO: 29.21 (-0.29), PSCH: 66.18 (+0.09), PJP: 75.81 (-0.55), RXD: 13.33 (+0.09)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 30.13 (-0.29), RXL: 138.47 (-1.10), XBI: 214.63 (-3.26), IBB: 337.47 (-3.33), IHE: 168.40 (-1.32), IHF: 127.24 (+0.23), BBC: 31.07 (-0.57), PPH: 69.20 (-0.28), XHE: 93.16 (-0.49), PTH: 58.61 (-0.63), BBH: 127.98 (-1.22), FHLC: 35.00 (-0.18), IHI: 119.02 (-0.51), CURE: 144.50 (-2.04), FXH: 64.53 (-0.35), VHT: 133.62 (-0.69), RYH: 151.78 (-0.58), PBE: 54.82 (-0.72), IYH: 153.01 (-0.71), FBT: 115.23 (-0.93), XHS: 120.36 (+0.82), XPH: 123.68 (-1.05), XLV: 72.24 (-0.35), SBIO: 29.21 (-0.29), PSCH: 66.18 (+0.09), PJP: 75.81 (-0.55), RXD: 13.33 (+0.09)
After Yesterday's Decline of 1.38%, Powershares Dynamic Pharmaceuticals Portfolio Offers Investors Better Value
Comtex SmarTrend(R) - Wed Dec 24, 4:54PM CST
Powershares Dynamic Pharmaceuticals Portfolio (AMEX
JP) traded in a range yesterday that spanned from a low of $65.45 to a high of $66.75. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $66.95 on volume of 181,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PJP: 75.81 (-0.55)
Bulls Rule As Volatility Recedes And Investors Position For Holiday Cheer
Scott Martindale - Seeking Alpha - Mon Nov 10, 9:10AM CST
After displaying a classic V-bottom reversal to what turned out to be a quick and anemic attempt by the bears to bring about a real correction, bullish fervor is becoming contagious, especially as the traditionally strong holiday season approaches....
ACT: 291.36 (+1.58), LUV: 43.24 (-0.84), IYZ: 30.82 (+0.18), SPY: 210.66 (-0.72), IDU: 113.61 (-0.04), AMAT: 25.05 (+0.14), JAZZ: 170.09 (-5.10), IYW: 108.77 (-0.54), FDX: 176.98 (+2.38), IYK: 107.88 (+0.21), IYJ: 110.11 (-0.44), XTN: 107.72 (-0.92), IYH: 153.01 (-0.71), LSTR: 70.22 (-0.23), SWKS: 87.75 (-0.83), IYM: 86.12 (-0.14), IYC: 144.46 (-0.32), NXPI: 84.89 (-0.07), SOXX: 96.86 (-0.29), IYF: 89.66 (-0.31), IYE: 44.69 (-0.13), ADM: 47.88 (+0.33), ARRS: 29.38 (+0.21), PJP: 75.81 (-0.55), ALXN: 180.37 (-2.74)
Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 1:00PM CDT
Pharma ETFs have been surging over the past one week buoyed by solid earnings from big industry players.
IHE: 168.40 (-1.32), JNJ: 102.51 (-0.29), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), MRK: 58.54 (-0.42), LLY: 70.17 (+0.14), BMY: 60.92 (-0.54)
New 52-Week Highs: Which Stock ETFs Are Shining The Brightest?
Gary Gordon - Seeking Alpha - Fri Oct 24, 11:15AM CDT
In spite of a stock market sell-off that nearly set the S&P 500 back 10%, some stock ETFs have already recovered. That's right. A handful of funds barely trembled during last week's frightful liquidation. Shortly thereafter, this intrepid group...
PJP: 75.81 (-0.55), SPHD: 33.11 (+0.01), VPU: 98.37 (-0.09), RHS: 109.62 (+0.44), USMV: 41.75 (-0.02)
True Fund Costs: Health Care Sector
David Trainer - Seeking Alpha - Tue Oct 21, 8:30AM CDT
This report focuses on providing investors the true costs incurred when investing in Health Care ETFs and mutual funds. A key component of our fund ratings, Total Annual Cost (TAC) accounts for all the costs borne by investors, including...
RXL: 138.47 (-1.10), PJP: 75.81 (-0.55), BIB: 153.74 (-2.94), PTH: 58.61 (-0.63), FXH: 64.53 (-0.35)
Healthcare ETFs for your Portfolio's Wellness - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Fri Sep 26, 10:56AM CDT
Healthcare sector has been beating the broader market and looks well poised to continue its outperformance in the longer term.
PJP: 75.81 (-0.55), VHT: 133.62 (-0.69), XLV: 72.24 (-0.35)
Pharma ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:00AM CDT
Rising demand from emerging markets and new products will continue to drive growth in the pharma industry.
IHE: 168.40 (-1.32), PJP: 75.81 (-0.55), XPH: 123.68 (-1.05)
Pharma ETFs In Focus On Valeant-Salix Deal
Zacks Funds - Seeking Alpha - Wed Feb 25, 6:44AM CST
After a blockbuster 2014, the healthcare space continues its mergers and acquisitions this year as well. The latest catalyst in the space is the Canadian drug maker Valeant Pharmaceuticals International (NYSE: VRX ), which is set to acquire leading...
PPH: 69.20 (-0.28), VRX: 197.48 (-3.77), PJP: 75.81 (-0.55), SLXP: 157.20 (+0.25), XPH: 123.68 (-1.05)
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Feb 24, 8:00AM CST
The M&A deal has put the pharma ETFs in focus over the coming days.
PPH: 69.20 (-0.28), VRX: 197.48 (-3.77), PJP: 75.81 (-0.55), SLXP: 157.20 (+0.25), XPH: 123.68 (-1.05)
Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 54.82 (-0.72), HQL: 28.10 (-0.22), FBT: 115.23 (-0.93), PJP: 75.81 (-0.55), XBI: 214.63 (-3.26), XPH: 123.68 (-1.05), IBB: 337.47 (-3.33), HQH: 35.19 (-0.24)
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 05, 10:00AM CST
How pharma ETFs are looking after the string of earnings beat and disappointing guidance?
IHE: 168.40 (-1.32), JNJ: 102.51 (-0.29), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), MRK: 58.54 (-0.42), PFE: 34.32 (-0.27), LLY: 70.17 (+0.14), BMY: 60.92 (-0.54)
Can Pharma ETFs Continue Their Uptrend In 2015?
Zacks Funds - Seeking Alpha - Fri Jan 09, 4:37PM CST
The pharmaceutical sector, which had been witnessing several tax inversion deals over the last few months, is not likely to go down this route given the Sep 2014 notice issued by the U.S. Department of the Treasury. New rules imposed by the Treasury...
IHE: 168.40 (-1.32), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), XPH: 123.68 (-1.05)
Can Pharma ETFs Continue their Uptrend in 2015? - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jan 09, 11:00AM CST
Several factors suggest that Pharma ETFs may continue their strong performance this year as well.
IHE: 168.40 (-1.32), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), XPH: 123.68 (-1.05)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 30.13 (-0.29), RXL: 138.47 (-1.10), XBI: 214.63 (-3.26), IHE: 168.40 (-1.32), IHF: 127.24 (+0.23), PPH: 69.20 (-0.28), XHE: 93.16 (-0.49), BBC: 31.07 (-0.57), PTH: 58.61 (-0.63), BBH: 127.98 (-1.22), FHLC: 35.00 (-0.18), IHI: 119.02 (-0.51), CURE: 144.50 (-2.04), FXH: 64.53 (-0.35), VHT: 133.62 (-0.69), RYH: 151.78 (-0.58), PBE: 54.82 (-0.72), IYH: 153.01 (-0.71), FBT: 115.23 (-0.93), XHS: 120.36 (+0.82), XPH: 123.68 (-1.05), XLV: 72.24 (-0.35), SBIO: 29.21 (-0.29), PSCH: 66.18 (+0.09), PJP: 75.81 (-0.55), RXD: 13.33 (+0.09)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 30.13 (-0.29), RXL: 138.47 (-1.10), XBI: 214.63 (-3.26), IBB: 337.47 (-3.33), IHE: 168.40 (-1.32), IHF: 127.24 (+0.23), BBC: 31.07 (-0.57), PPH: 69.20 (-0.28), XHE: 93.16 (-0.49), PTH: 58.61 (-0.63), BBH: 127.98 (-1.22), FHLC: 35.00 (-0.18), IHI: 119.02 (-0.51), CURE: 144.50 (-2.04), FXH: 64.53 (-0.35), VHT: 133.62 (-0.69), RYH: 151.78 (-0.58), PBE: 54.82 (-0.72), IYH: 153.01 (-0.71), FBT: 115.23 (-0.93), XHS: 120.36 (+0.82), XPH: 123.68 (-1.05), XLV: 72.24 (-0.35), SBIO: 29.21 (-0.29), PSCH: 66.18 (+0.09), PJP: 75.81 (-0.55), RXD: 13.33 (+0.09)
After Yesterday's Decline of 1.38%, Powershares Dynamic Pharmaceuticals Portfolio Offers Investors Better Value
Comtex SmarTrend(R) - Wed Dec 24, 4:54PM CST
Powershares Dynamic Pharmaceuticals Portfolio (AMEX
JP) traded in a range yesterday that spanned from a low of $65.45 to a high of $66.75. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $66.95 on volume of 181,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. PJP: 75.81 (-0.55)
Bulls Rule As Volatility Recedes And Investors Position For Holiday Cheer
Scott Martindale - Seeking Alpha - Mon Nov 10, 9:10AM CST
After displaying a classic V-bottom reversal to what turned out to be a quick and anemic attempt by the bears to bring about a real correction, bullish fervor is becoming contagious, especially as the traditionally strong holiday season approaches....
ACT: 291.36 (+1.58), LUV: 43.24 (-0.84), IYZ: 30.82 (+0.18), SPY: 210.66 (-0.72), IDU: 113.61 (-0.04), AMAT: 25.05 (+0.14), JAZZ: 170.09 (-5.10), IYW: 108.77 (-0.54), FDX: 176.98 (+2.38), IYK: 107.88 (+0.21), IYJ: 110.11 (-0.44), XTN: 107.72 (-0.92), IYH: 153.01 (-0.71), LSTR: 70.22 (-0.23), SWKS: 87.75 (-0.83), IYM: 86.12 (-0.14), IYC: 144.46 (-0.32), NXPI: 84.89 (-0.07), SOXX: 96.86 (-0.29), IYF: 89.66 (-0.31), IYE: 44.69 (-0.13), ADM: 47.88 (+0.33), ARRS: 29.38 (+0.21), PJP: 75.81 (-0.55), ALXN: 180.37 (-2.74)
Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 1:00PM CDT
Pharma ETFs have been surging over the past one week buoyed by solid earnings from big industry players.
IHE: 168.40 (-1.32), JNJ: 102.51 (-0.29), PPH: 69.20 (-0.28), PJP: 75.81 (-0.55), MRK: 58.54 (-0.42), LLY: 70.17 (+0.14), BMY: 60.92 (-0.54)
New 52-Week Highs: Which Stock ETFs Are Shining The Brightest?
Gary Gordon - Seeking Alpha - Fri Oct 24, 11:15AM CDT
In spite of a stock market sell-off that nearly set the S&P 500 back 10%, some stock ETFs have already recovered. That's right. A handful of funds barely trembled during last week's frightful liquidation. Shortly thereafter, this intrepid group...
PJP: 75.81 (-0.55), SPHD: 33.11 (+0.01), VPU: 98.37 (-0.09), RHS: 109.62 (+0.44), USMV: 41.75 (-0.02)
True Fund Costs: Health Care Sector
David Trainer - Seeking Alpha - Tue Oct 21, 8:30AM CDT
This report focuses on providing investors the true costs incurred when investing in Health Care ETFs and mutual funds. A key component of our fund ratings, Total Annual Cost (TAC) accounts for all the costs borne by investors, including...
RXL: 138.47 (-1.10), PJP: 75.81 (-0.55), BIB: 153.74 (-2.94), PTH: 58.61 (-0.63), FXH: 64.53 (-0.35)
Healthcare ETFs for your Portfolio's Wellness - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Fri Sep 26, 10:56AM CDT
Healthcare sector has been beating the broader market and looks well poised to continue its outperformance in the longer term.
PJP: 75.81 (-0.55), VHT: 133.62 (-0.69), XLV: 72.24 (-0.35)
Pharma ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:00AM CDT
Rising demand from emerging markets and new products will continue to drive growth in the pharma industry.
IHE: 168.40 (-1.32), PJP: 75.81 (-0.55), XPH: 123.68 (-1.05)
(0)
(0)